April 20, 2011 - Healthcare Private Equity Wednesday Webinar Series
Archived media:
Healthcare and life sciences companies do business in a heated regulatory enforcement environment. Buyers of healthcare and life sciences companies are placing increasing scrutiny on target companies’ compliance with healthcare laws and regulations. As such, it’s becoming more and more common for due diligence of potential portfolio companies to uncover actual and potential violations of laws and regulations.
Topics
Speakers
For information on McGuireWoods events and seminars, click here.